BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23752089)

  • 1. Value of SOX10 immunostaining in tumor diagnosis.
    Ordóñez NG
    Adv Anat Pathol; 2013 Jul; 20(4):275-83. PubMed ID: 23752089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas.
    Tacha D; Qi W; Ra S; Bremer R; Yu C; Chu J; Hoang L; Robbins B
    Arch Pathol Lab Med; 2015 Apr; 139(4):530-6. PubMed ID: 25436903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sox10: a pan-schwannian and melanocytic marker.
    Nonaka D; Chiriboga L; Rubin BP
    Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of GATA3 immunostaining in tumor diagnosis: a review.
    Ordóñez NG
    Adv Anat Pathol; 2013 Sep; 20(5):352-60. PubMed ID: 23939152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX10 expression distinguishes desmoplastic melanoma from its histologic mimics.
    Palla B; Su A; Binder S; Dry S
    Am J Dermatopathol; 2013 Jul; 35(5):576-81. PubMed ID: 23291581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sox10 nuclear immunostaining lacks diagnostic utility for CNS granular cell tumors.
    Wisell J; Kleinschmidt-DeMasters BK
    J Neuropathol Exp Neurol; 2014 Jan; 73(1):98-100. PubMed ID: 24335528
    [No Abstract]   [Full Text] [Related]  

  • 7. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.
    Ramos-Herberth FI; Karamchandani J; Kim J; Dadras SS
    J Cutan Pathol; 2010 Sep; 37(9):944-52. PubMed ID: 20653825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
    J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newly available antibodies with practical applications in surgical pathology.
    Chan JK
    Int J Surg Pathol; 2013 Dec; 21(6):553-72. PubMed ID: 24225578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of Sox10 immunohistochemical staining for the detection of metastatic melanoma in sentinel lymph nodes.
    Blochin E; Nonaka D
    Histopathology; 2009 Nov; 55(5):626-8. PubMed ID: 19912373
    [No Abstract]   [Full Text] [Related]  

  • 11. Biphenotypic sinonasal sarcoma: an expanded immunoprofile including consistent nuclear β-catenin positivity and absence of SOX10 expression.
    Rooper LM; Huang SC; Antonescu CR; Westra WH; Bishop JA
    Hum Pathol; 2016 Sep; 55():44-50. PubMed ID: 27137987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.
    Bakos RM; Maier T; Besch R; Mestel DS; Ruzicka T; Sturm RA; Berking C
    Exp Dermatol; 2010 Aug; 19(8):e89-94. PubMed ID: 19845757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX10 expression in superficial spreading and nodular malignant melanomas.
    Agnarsdóttir M; Sooman L; Bolander A; Strömberg S; Rexhepaj E; Bergqvist M; Ponten F; Gallagher W; Lennartsson J; Ekman S; Uhlen M; Hedstrand H
    Melanoma Res; 2010 Dec; 20(6):468-78. PubMed ID: 20890226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Expression Profiling of Head and Neck Tumors Identifies FOXP1 and SOX10 Expression as Useful for Distinguishing Ameloblastoma From Basaloid Salivary Gland Tumors.
    Ko YCK; Varma S; Zhu CF; Zhu SX; Vennam S; Poh CF; Jordan RC; Kong C; Pollack JR; West RB
    Am J Surg Pathol; 2020 May; 44(5):665-672. PubMed ID: 31895100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of PAX2 immunostaining in tumor diagnosis: a review and update.
    Ordóñez NG
    Adv Anat Pathol; 2012 Nov; 19(6):401-9. PubMed ID: 23060065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sox10 overexpression induces neural crest-like cells from all dorsoventral levels of the neural tube but inhibits differentiation.
    McKeown SJ; Lee VM; Bronner-Fraser M; Newgreen DF; Farlie PG
    Dev Dyn; 2005 Jun; 233(2):430-44. PubMed ID: 15768395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors.
    Miettinen M; McCue PA; Sarlomo-Rikala M; Biernat W; Czapiewski P; Kopczynski J; Thompson LD; Lasota J; Wang Z; Fetsch JF
    Am J Surg Pathol; 2015 Jun; 39(6):826-35. PubMed ID: 25724000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural crest cells retain their capability for multipotential differentiation even after lineage-restricted stages.
    Motohashi T; Yamanaka K; Chiba K; Miyajima K; Aoki H; Hirobe T; Kunisada T
    Dev Dyn; 2011 Jul; 240(7):1681-93. PubMed ID: 21594952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox10-Positive Cells Within Scars: A Potential Diagnostic Pitfall.
    Harvey NT; Acott NJ; Wood BA
    Am J Dermatopathol; 2017 Oct; 39(10):791-793. PubMed ID: 27759704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.